vs
AVANOS MEDICAL, INC.（AVNS）与Ranger Energy Services, Inc.（RNGR）财务数据对比。点击上方公司名可切换其他公司
AVANOS MEDICAL, INC.的季度营收约是Ranger Energy Services, Inc.的1.3倍（$180.9M vs $142.2M），Ranger Energy Services, Inc.净利率更高（2.3% vs -0.7%，领先3.0%），AVANOS MEDICAL, INC.同比增速更快（0.7% vs -0.6%），AVANOS MEDICAL, INC.自由现金流更多（$21.3M vs $17.1M），过去两年AVANOS MEDICAL, INC.的营收复合增速更高（4.4% vs 1.9%）
Avanos Medical是一家医疗科技企业，专注于研发生产临床医疗设备，核心业务围绕疼痛管理与慢性护理两大板块展开，致力于帮助患者加快康复、预防感染，同时减少临床治疗中阿片类药物的使用。
Ranger Energy Services是北美领先的陆上油田服务提供商，为上游油气运营商提供完井、修井、钻机作业及产能优化等全套解决方案，业务主要覆盖美国本土的页岩和致密资源开采作业区。
AVNS vs RNGR — 直观对比
营收规模更大
AVNS
是对方的1.3倍
$142.2M
营收增速更快
AVNS
高出1.4%
-0.6%
净利率更高
RNGR
高出3.0%
-0.7%
自由现金流更多
AVNS
多$4.2M
$17.1M
两年增速更快
AVNS
近两年复合增速
1.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $180.9M | $142.2M |
| 净利润 | $-1.3M | $3.2M |
| 毛利率 | 47.5% | — |
| 营业利润率 | 1.4% | 2.3% |
| 净利率 | -0.7% | 2.3% |
| 营收同比 | 0.7% | -0.6% |
| 净利润同比 | 99.7% | -44.8% |
| 每股收益（稀释后） | $-0.02 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVNSRNGR
| Q4 25 | $180.9M | $142.2M | ||
| Q3 25 | $177.8M | $128.9M | ||
| Q2 25 | $175.0M | $140.6M | ||
| Q1 25 | $167.5M | $135.2M | ||
| Q4 24 | $179.6M | $143.1M | ||
| Q3 24 | $170.4M | $153.0M | ||
| Q2 24 | $171.7M | $138.1M | ||
| Q1 24 | $166.1M | $136.9M |
净利润AVNSRNGR
| Q4 25 | $-1.3M | $3.2M | ||
| Q3 25 | $-1.4M | $1.2M | ||
| Q2 25 | $-76.8M | $7.3M | ||
| Q1 25 | $6.6M | $600.0K | ||
| Q4 24 | $-397.3M | $5.8M | ||
| Q3 24 | $4.3M | $8.7M | ||
| Q2 24 | $1.8M | $4.7M | ||
| Q1 24 | $-900.0K | $-800.0K |
毛利率AVNSRNGR
| Q4 25 | 47.5% | — | ||
| Q3 25 | 48.4% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 54.6% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 57.1% | — |
营业利润率AVNSRNGR
| Q4 25 | 1.4% | 2.3% | ||
| Q3 25 | 0.1% | 2.0% | ||
| Q2 25 | -42.6% | 6.1% | ||
| Q1 25 | 6.1% | 0.7% | ||
| Q4 24 | -233.0% | 6.2% | ||
| Q3 24 | 7.0% | 8.4% | ||
| Q2 24 | 3.7% | 5.3% | ||
| Q1 24 | 2.4% | -0.4% |
净利率AVNSRNGR
| Q4 25 | -0.7% | 2.3% | ||
| Q3 25 | -0.8% | 0.9% | ||
| Q2 25 | -43.9% | 5.2% | ||
| Q1 25 | 3.9% | 0.4% | ||
| Q4 24 | -221.2% | 4.1% | ||
| Q3 24 | 2.5% | 5.7% | ||
| Q2 24 | 1.0% | 3.4% | ||
| Q1 24 | -0.5% | -0.6% |
每股收益（稀释后）AVNSRNGR
| Q4 25 | $-0.02 | $0.14 | ||
| Q3 25 | $-0.03 | $0.05 | ||
| Q2 25 | $-1.66 | $0.32 | ||
| Q1 25 | $0.14 | $0.03 | ||
| Q4 24 | $-8.64 | $0.24 | ||
| Q3 24 | $0.09 | $0.39 | ||
| Q2 24 | $0.04 | $0.21 | ||
| Q1 24 | $-0.02 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.8M | $10.3M |
| 总债务越低越好 | $90.3M | — |
| 股东权益账面价值 | $778.2M | $300.1M |
| 总资产 | $1.1B | $419.3M |
| 负债/权益比越低杠杆越低 | 0.12× | — |
8季度趋势，按日历期对齐
现金及短期投资AVNSRNGR
| Q4 25 | $89.8M | $10.3M | ||
| Q3 25 | $70.5M | $45.2M | ||
| Q2 25 | $90.3M | $48.9M | ||
| Q1 25 | $97.0M | $40.3M | ||
| Q4 24 | $107.7M | $40.9M | ||
| Q3 24 | $89.0M | $14.8M | ||
| Q2 24 | $92.2M | $8.7M | ||
| Q1 24 | $75.8M | $11.1M |
总债务AVNSRNGR
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | $0 | ||
| Q3 24 | $152.6M | $0 | ||
| Q2 24 | $164.9M | $0 | ||
| Q1 24 | $167.2M | $0 |
股东权益AVNSRNGR
| Q4 25 | $778.2M | $300.1M | ||
| Q3 25 | $778.0M | $270.0M | ||
| Q2 25 | $776.3M | $276.9M | ||
| Q1 25 | $839.4M | $272.6M | ||
| Q4 24 | $828.5M | $273.8M | ||
| Q3 24 | $1.2B | $267.6M | ||
| Q2 24 | $1.2B | $260.5M | ||
| Q1 24 | $1.2B | $261.7M |
总资产AVNSRNGR
| Q4 25 | $1.1B | $419.3M | ||
| Q3 25 | $1.1B | $372.8M | ||
| Q2 25 | $1.0B | $381.7M | ||
| Q1 25 | $1.1B | $376.5M | ||
| Q4 24 | $1.2B | $381.6M | ||
| Q3 24 | $1.7B | $373.9M | ||
| Q2 24 | $1.7B | $359.6M | ||
| Q1 24 | $1.7B | $355.5M |
负债/权益比AVNSRNGR
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | 0.00× | ||
| Q3 24 | 0.12× | 0.00× | ||
| Q2 24 | 0.13× | 0.00× | ||
| Q1 24 | 0.14× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.2M | $24.1M |
| 自由现金流经营现金流 - 资本支出 | $21.3M | $17.1M |
| 自由现金流率自由现金流/营收 | 11.8% | 12.0% |
| 资本支出强度资本支出/营收 | 3.8% | 4.9% |
| 现金转化率经营现金流/净利润 | — | 7.53× |
| 过去12个月自由现金流最近4个季度 | $43.1M | $42.9M |
8季度趋势，按日历期对齐
经营现金流AVNSRNGR
| Q4 25 | $28.2M | $24.1M | ||
| Q3 25 | $14.0M | $13.6M | ||
| Q2 25 | $6.8M | $20.7M | ||
| Q1 25 | $25.7M | $10.6M | ||
| Q4 24 | $57.9M | $32.7M | ||
| Q3 24 | $23.0M | $17.7M | ||
| Q2 24 | $27.8M | $22.1M | ||
| Q1 24 | $-8.0M | $12.0M |
自由现金流AVNSRNGR
| Q4 25 | $21.3M | $17.1M | ||
| Q3 25 | $7.0M | $8.0M | ||
| Q2 25 | $-4.2M | $14.4M | ||
| Q1 25 | $19.0M | $3.4M | ||
| Q4 24 | $53.1M | $27.3M | ||
| Q3 24 | $20.0M | $10.8M | ||
| Q2 24 | $21.9M | $6.8M | ||
| Q1 24 | $-12.1M | $5.5M |
自由现金流率AVNSRNGR
| Q4 25 | 11.8% | 12.0% | ||
| Q3 25 | 3.9% | 6.2% | ||
| Q2 25 | -2.4% | 10.2% | ||
| Q1 25 | 11.3% | 2.5% | ||
| Q4 24 | 29.6% | 19.1% | ||
| Q3 24 | 11.7% | 7.1% | ||
| Q2 24 | 12.8% | 4.9% | ||
| Q1 24 | -7.3% | 4.0% |
资本支出强度AVNSRNGR
| Q4 25 | 3.8% | 4.9% | ||
| Q3 25 | 3.9% | 4.3% | ||
| Q2 25 | 6.3% | 4.5% | ||
| Q1 25 | 4.0% | 5.3% | ||
| Q4 24 | 2.7% | 3.8% | ||
| Q3 24 | 1.8% | 4.5% | ||
| Q2 24 | 3.4% | 11.1% | ||
| Q1 24 | 2.5% | 4.7% |
现金转化率AVNSRNGR
| Q4 25 | — | 7.53× | ||
| Q3 25 | — | 11.33× | ||
| Q2 25 | — | 2.84× | ||
| Q1 25 | 3.89× | 17.67× | ||
| Q4 24 | — | 5.64× | ||
| Q3 24 | 5.35× | 2.03× | ||
| Q2 24 | 15.44× | 4.70× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
RNGR
| High Specification Rigs | $92.3M | 65% |
| Processing Solutions And Ancillary Services | $37.5M | 26% |
| Wireline Services | $12.4M | 9% |
